Ind-Swift Laboratories to consider fund raising on July 10, 2026

Ind-Swift Laboratories Ltd has announced that its Board of Directors will convene on July 10, 2026. The primary agenda item is to consider and approve proposals for raising funds. The company may issue equity shares, convertible securities, or utilize other instruments through methods such as Preferential Issue, Rights Issue, or QIP. The specific modalities and pricing will also be determined during the meeting. Concurrently, the trading window for the company's securities remains closed until 48 hours after the board meeting, in line with SEBI regulations and the company's insider trading policy, due to the pending declaration of financial results.